GetTopicDetailResponse(id=4e7386e5810, topicName=艾多沙班, introduction=艾多沙班, content=null, image=null, comments=5, allHits=3433, url=https://h5.medsci.cn/topic?id=86758, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=79141, tagList=[TagDto(tagId=79141, tagName=艾多沙班)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1241566, encodeId=8360124156664, content=<a href='/topic/show?id=4e7386e5810' target=_blank style='color:#2F92EE;'>#艾多沙班#</a>、<a href='/topic/show?id=decb3226811' target=_blank style='color:#2F92EE;'>#利伐沙班#</a>和<a href='/topic/show?id=95089e7452f' target=_blank style='color:#2F92EE;'>#阿哌沙班#</a>在<a href='/topic/show?id=5471991e9f3' target=_blank style='color:#2F92EE;'>#靜脈血栓栓塞#</a><a href='/topic/show?id=23c58911686' target=_blank style='color:#2F92EE;'>#血栓栓塞#</a>, objectTitle=J Thromb Haemost：艾多沙班、利伐沙班和阿哌沙班在靜脈血栓栓塞患者中的療效和安全性比較, objectType=article, longId=730707, objectId=45e3e3070798, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20220627/1656343907354_1739456.jpg, objectUrl=/article/show_article.do?id=45e3e3070798, replyNumber=0, likeNumber=0, createdTime=2022-08-28, rootId=0, userName=循證小兵, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45e3e3070798, moduleTitle=J Thromb Haemost：艾多沙班、利伐沙班和阿哌沙班在靜脈血栓栓塞患者中的療效和安全性比較, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=45e3e3070798)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1220318, encodeId=819d1220318a8, content=<a href='/topic/show?id=4e7386e5810' target=_blank style='color:#2F92EE;'>#艾多沙班#</a>與<a href='/topic/show?id=c3cc35912aa' target=_blank style='color:#2F92EE;'>#華法林#</a>的<a href='/topic/show?id=baaa1020837e' target=_blank style='color:#2F92EE;'>#髖部骨折#</a>風險分析, objectTitle=Bone：艾多沙班與華法林的髖部骨折風險分析, objectType=article, longId=293507, objectId=de7729350ee3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202215/1641390761938_5295905.jpg, objectUrl=/article/show_article.do?id=de7729350ee3, replyNumber=0, likeNumber=174, createdTime=2022-05-17, rootId=0, userName=賽華佗, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=de7729350ee3, moduleTitle=Bone：艾多沙班與華法林的髖部骨折風險分析, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=de7729350ee3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1197204, encodeId=dee3119e2049f, content=<a href='/topic/show?id=4e7386e5810' target=_blank style='color:#2F92EE;'>#艾多沙班#</a>艾多沙班對LAC陽性患者的VTE/PE復(fù)發(fā)的預(yù)防治療安全有效，且不會發(fā)生動脈事件。, objectTitle=艾多沙班, objectType=topic, longId=86758, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=98, createdTime=2022-02-25, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=998194, encodeId=710499819435, content=<a href='/topic/show?id=4e7386e5810' target=_blank style='color:#2F92EE;'>#艾多沙班#</a>艾多沙班抗凝作用強，安全性也可以。, objectTitle=艾多沙班, objectType=topic, longId=86758, objectId=null, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=null, replyNumber=0, likeNumber=0, createdTime=2021-07-10, rootId=0, userName=yangchou, userId=88b489038, projectId=1, avatar=, status=1, hasArticle=0, attachment=null, ipAttribution=, moduleDTOList=null, followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=895318, encodeId=acbe89531888, content=<a href='/topic/show?id=5aae26890c0' target=_blank style='color:#2F92EE;'>#依度沙班#</a>和<a href='/topic/show?id=4e7386e5810' target=_blank style='color:#2F92EE;'>#艾多沙班#</a>在老年人中都是相當安全的, objectTitle=ESC 2020：艾多沙班15 mg，耄耋老人的抗凝新方案：ELDECARE-AF研究解讀, objectType=article, longId=200207, objectId=221920020ee9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20200828/2fb475f5e52c48c5b59840b47ccf387f.jpg, objectUrl=/article/show_article.do?id=221920020ee9, replyNumber=0, likeNumber=257, createdTime=2020-10-29, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=221920020ee9, moduleTitle=ESC 2020：艾多沙班15 mg，耄耋老人的抗凝新方案：ELDECARE-AF研究解讀, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=221920020ee9)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
